SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is at the center of intense debate following a cryptic social media post from its CEO regarding balance sheet strengthening and global expansion, fueling speculation about potential non-dilutive capital or strategic partnerships. While some investors fear further dilution, the community is largely focused on upcoming international expansion milestones and potential government-backed funding, viewing the current volatility as a battleground between persistent short-selling pressure and long-term bullish conviction in the company's clinical pipeline.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is trending due to significant overnight volatility triggered by conflicting reports regarding a potential wind-down of the Iran conflict, sparking intense debate among investors about the durability of the current market pump. Community sentiment remains polarized, with many traders labeling the rally a "fake" move or a bull trap, while others are closely monitoring technical levels and geopolitical developments for signs of a more sustainable relief rally.

Spdr Dow Jones Industrial Average ETF Trust - Units of undivided interest in DIAMONDS Trust Series 1

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market volatility as investors weigh conflicting reports over the potential resolution of the U.S. military campaign in Iran. While some traders are reacting to speculative optimism regarding a diplomatic wind-down, the community remains deeply divided, with many debating the impact of energy supply disruptions and the sustainability of market rallies amidst persistent geopolitical uncertainty.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN) is trending as retail investors engage in a polarized debate over its transition into the crypto space, with some community members promoting it as a community-driven project while many others dismiss it as a continuation of previous stock-based manipulation schemes. Sentiment remains heavily divided, with vocal critics highlighting past dilution and reverse splits, while optimistic supporters focus on its potential as a grassroots movement.

Maul Coin

Maul Coin is currently trending as community members rally to push the token toward a bonding curve completion while advocating for broader platform visibility and a price surge. Supporters are actively engaging on social platforms to build organic momentum, framing the project as a community-driven alternative to other memecoins and larger market volatility.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing significant downward pressure as it navigates a broader tech sector sell-off and investor apprehension regarding geopolitical instability in the Middle East. While retail sentiment remains deeply polarized between those betting on long-term AI-driven fundamental growth and those expecting a deeper valuation reset, the community is actively debating whether the current pullback represents a strategic buying opportunity or a signal of structural weakness.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy Co. is attracting significant trading activity and momentum following its recent business combination and Nasdaq debut, fueled by strategic partnerships in Arctic oil exploration. Investors are actively debating the stock's potential as a major energy play, with discussions heavily focused on the company's access to massive unrisked oil reserves in Greenland's Jameson Land Basin and ongoing geopolitical tensions in global energy markets.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors weigh escalating geopolitical tensions in the Middle East, specifically reports of tanker attacks and blocked shipping routes in the Strait of Hormuz, against mixed signals from U.S. leadership regarding diplomatic negotiations. The community remains deeply divided, with some traders betting on further supply-driven price surges toward historic highs, while others argue that aggressive market rhetoric is merely noise masking institutional manipulation or the potential for a sudden, policy-driven pullback.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is trending as traders navigate extreme volatility fueled by uncertainty over the U.S. military presence in Iran and fluctuating oil prices. Community sentiment is deeply divided, with many market participants actively debating the impact of geopolitical news leaks on price action while cautioning one another about potential bull traps amidst the ongoing market instability.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets (SSB) is currently seeing significant community activity driven by the momentum of Maulcoin, with holders actively lobbying for chart support on major platforms. Investors remain focused on the broader ecosystem's development and are closely monitoring price action for signs of stability and growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Journey Medical (NASDAQ:DERM - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by...

HC Wainwright Forecasts Journey Medical Q1 Earnings

Journey Medical Corporation (NASDAQ:DERM - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Journey Medical in a research report issued to clients...

Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Journey Medical (DERM) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HC Wainwright Reaffirms Buy Rating for Journey Medical (NASDAQ:DERM)

HC Wainwright restated a "buy" rating and set a $13.00 target price on shares of Journey Medical in a research report on Thursday...

Journey Medical Q4 Earnings Call Highlights

Journey Medical (NASDAQ:DERM) executives highlighted a milestone 2025 marked by the commercial launch of EMROSI, an internally developed oral treatment for the inflammatory lesions of rosacea, and...

Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday

Journey Medical (NASDAQ:DERM) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 25. (View Earnings Report at...

Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been given an average recommendation of "Hold" by the five ratings firms that are presently covering the stock, MarketBeat.com reports...

Journey Medical (NASDAQ:DERM) Shares Down 3.5% - What's Next?

Journey Medical (NASDAQ:DERM) Shares Down 3.5% - Here's What Happened...

Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are currently covering the company, MarketBeat.com reports...

Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been given an average rating of "Hold" by the five brokerages that are currently covering the company, MarketBeat.com reports. One...

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

DERM
Journey Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DERM News

DERMJourney Medical Corp